Abstract:Introduction: Osteogenesis imperfecta (OI) is a group of phenotypically and genetically heterogeneous connective tissue disorders that share similar skeletal anomalies causing bone fragility and deformation. This study aimed to investigate the molecular genetic etiology and determine the relationship between genotype and phenotype in OI patients with targeted next-generation sequencing (NGS). Method: In patients with OI, a targeted NGS analysis panel (Illumina TruSight One) containing genes involved in collagen/bone synthesis was performed on the Illumina Nextseq550 platform. Results: Fifty-six patients (female/male: 25/31) from 46 different families were enrolled in the study. Consanguinity between parents was noted in 15 (32.6%) families. Clinically according to Sillence classification; 18(33.1%) patients were considered to type I, 1(1.7%) type II, 26(46.4%) type III and 11(19.6%) type IV. Median body weight was -1.1 (-6.8, - 2.5) SDS, and height was -2.3 (-7.6, - 1.2) SDS. Bone deformity was detected in 30 (53.5%) of the patients, while 31 (55.4%) were evaluated as mobile. Thirty-six (60.7%) patients had blue sclera, 13 (23.2%) had scoliosis, 12 (21.4%) had dentinogenesis imperfecta (DI), and 2 (3.6%) had hearing loss. Disease-causing variants in COL1A1 and COL1A2 genes were found in 24 (52.1%) and 6 (13%) families, respectively. In 8 (17.3%) of the remaining 16 (34.7%) families, the NGS panel revealed disease-causing variants in three different genes (FKBP10, SERPINF1, and P3H1). Nine (23.6%) of the variants detected in all investigated genes were not previously reported in the literature and were classified to be pathogenic according to ACMG guidelines pathogenity scores. In ten (21.7%) families, a disease-related variant was not found in a total of 13 OI genes included in the panel. Conclusion: Genetic etiology was found in 38 (82.6%) of 46 families by targeted NGS analysis. In addition, 9 new variants were assessed in known OI genes which is a significant contribution to the literature.

A Dyadic Nosology for Osteogenesis Imperfecta and Bone Fragility Syndromes 2024

Molecular Genetic Diagnosis with Targeted Next Generation Sequencing in a Cohort of Turkish Osteogenesis Imperfecta Patients and Their Genotype-phenotype Correlation

Current Overview of Osteogenesis Imperfecta

Genotype and Phenotype Correlation of Patients with Osteogenesis Imperfecta

Osteogenesis Imperfecta: Skeletal and Non-skeletal Challenges in Adulthood

Osteogenesis Imperfecta: A study of the patient journey in 13 European countries

Recent Progress in Osteogenesis Imperfecta

Genotype and Phenotype Analysis of Taiwanese Patients with Osteogenesis Imperfecta

Osteogenesis Imperfecta: Current and Prospective Therapies

Clinical spectrum of rare bone fragility disorders and response to bisphosphonate treatment: a retrospective study

Management of Osteogenesis Imperfecta

Effectiveness of whole exome sequencing analyses in the molecular diagnosis of osteogenesis imperfecta

Application of Next-Generation Sequencing for Molecular Diagnosis in a Large Family with Osteogenesis Imperfecta Type I

Genetic Anomalies in Pediatric Orthopedics: A Case Study of a New Rare Sporadic Mutation of Osteogenesis Imperfecta

Prevalence and Hospital Admissions in Patients With Osteogenesis Imperfecta in The Netherlands: A Nationwide Registry Study

Emerging Landscape of Osteogenesis Imperfecta Pathogenesis and Therapeutic Approaches

The genetic implication of scoliosis in osteogenesis imperfecta: a review.

Letter to the editor: Re: Pathogenic mechanisms of osteogenesis imperfecta, evidence for classification

Dual Diagnosis of Osteogenesis Imperfecta (OI) and Short Stature and Advanced Bone Age with or Without Early-Onset Osteoarthritis And/or Osteochondritis Dissecans (SSOAOD) Reveals a Cumulative Effect on Stature Caused by Mutations in COL1A1 and ACAN Genes.

Current concepts in osteogenesis imperfecta: Bone structure, biomechanics and medical management

Bone fragility in patients affected by congenital diseases non skeletal in origin